GlaxoSmithKline Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.93%34.190.9%$1186.82m
JNJJohnson & Johnson 0.40%143.550.7%$1104.39m
BMYBristol-Myers Squibb Co. 0.12%60.261.0%$995.35m
MRKMerck & Co., Inc. -0.63%79.080.7%$850.48m
ABBVAbbVie, Inc. 0.63%99.631.9%$797.95m
LLYEli Lilly & Co. 0.42%167.591.1%$708.10m
AZNAstraZeneca Plc -0.44%53.861.2%$302.07m
VXRTVaxart, Inc. 21.12%7.800.0%$254.56m
RPRXRoyalty Pharma Plc 1.29%46.710.1%$244.39m
NVSNovartis AG -0.42%88.090.2%$159.41m
RGENRepligen Corp. -0.84%125.537.1%$121.64m
GSKGlaxoSmithKline Plc -1.02%40.590.2%$119.74m
NVONovo Nordisk A/S -0.88%65.340.1%$94.42m
RETAReata Pharmaceuticals, Inc. -1.20%158.503.4%$85.24m
SNYSanofi -1.07%51.640.2%$76.24m

Company Profile

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.